Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Compare major budgeting methods side by side, highlighting effectiveness, flexibility, and suitability for different financial contexts.
27,828 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Fundamental-indexing ETFs that ignore market-cap weights are drawing attention as 2026 market conditions test traditi...
The U.S. shipbuilding industry is looming a 250,000-worker gap over the next decade, even as the Trump administration...
The FDA approved two fruit-flavored vape lines from a Los Angeles company, a notable policy reversal that comes as po...
KeyBanc cut McDonald’s price target to $330 following a quarterly beat, citing softer April results and challenging y...
Bitcoin hovered near $80,000 as U.S. inflation surged to 3.8% in April, the strongest reading since May 2023, signali...
Micron Technology rides a rapid AI-fueled rally into May, fueling debate among investors about whether to sell or hol...
As CME Group and ICE push 24/7 crypto trading, a heated clash with an offshore venue shines a spotlight on who contro...
Nebius Group flags a fragile link between borrowing costs and AI investment. The remarks underscore how rate moves fr...
Researchers report clues that AI seems turn marxist after heavy workloads, raising questions for workers and investor...
OpenAI is moving toward a potential trillion-dollar IPO, with confidential SEC filings reportedly underway and a Sept...
Retail investors push Ford into meme-stock territory as Wall Street holds, sparking a heated debate about the automak...